Published: 17 Feb 2025(Updated: 17 Feb 2025)

•36 min

•36 min read

•Denise Haslwanter, M Eugenia Dieterle, Anna Z Wec, Cecilia M O’Brien, Mrunal Sakharkar, Catalina Florez, Karen Tong, C Garrett Rappazzo, Gorka Lasso a, Olivia Vergnolle, Ariel S Wirchnianski +

A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape Mutants

Cell culture

Researchers from Albert Einstein College of Medicine, Adimab LLC, and the U.S. Army Medical Research Institute of Infectious Diseases explored how combining neutralizing antibodies targeting different parts of the SARS-CoV-2 spike protein can help prevent escape mutants. Using the INFORS HT Multitron incubator shaker, they cultivated cells under controlled conditions to test antibody effectiveness. Their approach could strengthen antibody-based COVID-19 treatments by improving effectiveness and reducing resistance.

Access the full research article Featured product: Multitron incubator shaker

We care about your privacy

We use cookies to improve user experience. We analyse our traffic, we personalise content and ads on our website, and we provide social media features. Certain cookies are necessary for our website to work properly and to enable you to use its features. With your consent, we also use analytics cookies to improve our website and marketing cookies to display advertisements and content on our website.